Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Hematopoietic cell lineage	3/99	0.00020131554786600544	0.014494719446352392	35.589285714285715	-70.42440314178907	CD34;IL6;THPO
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.01992154026178971	17.769924812030077	-37.496518500419114	CXCL8;HLA-A;IL6
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	3/219	0.0020484263518845244	0.01992154026178971	15.579365079365079	-32.91284230349772	HLA-A;IL6;TERT
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.01992154026178971	15.146718146718147	-31.989452913184095	CXCL8;HLA-A;IL6
KEGG_2021_Human	Cellular senescence	3/156	0.0007673816433603202	0.01992154026178971	22.170868347338935	-46.2873867313738	CXCL8;HLA-A;IL6
KEGG_2021_Human	Legionellosis	2/57	0.0021229405609363423	0.01992154026178971	36.42272727272727	-44.890022889750604	CXCL8;IL6
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.01992154026178971	50.175	-57.95352918467438	HLA-A;IL6
KEGG_2021_Human	Malaria	2/50	0.0016370061401984127	0.01992154026178971	41.770833333333336	-50.1560330081587	CXCL8;IL6
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.022538786168869875	9.539531941808981	-25.060320343159585	CXCL8;IL6;TERC;TERT
KEGG_2021_Human	Pertussis	2/76	0.0037436519554145367	0.026954294078984663	27.006756756756758	-34.90410589940028	CXCL8;IL6
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.027625597712665116	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.027625597712665116	19.524509803921568	-26.130280011490946	CXCL8;IL6
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.027625597712665116	21.914835164835164	-29.03004575134454	CXCL8;IL6
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.027625597712665116	11.412915851272016	-23.74866982495136	CXCL8;IL6;THPO
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.027625597712665116	19.92	-26.61700675496218	CXCL8;IL6
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	2/100	0.006399778215208473	0.027625597712665116	20.331632653061224	-27.120602948412195	CXCL8;IL6
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.005673660825135872	0.027625597712665116	21.67391304347826	-28.742216935482162	CXCL8;IL6
KEGG_2021_Human	Amoebiasis	2/102	0.006650847322673755	0.027625597712665116	19.92	-26.61700675496218	CXCL8;IL6
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.04453919157492651	14.690740740740742	-19.931093924152265	CXCL8;IL6
KEGG_2021_Human	Gastric cancer	2/149	0.013800829937106646	0.04731713121293707	13.47108843537415	-18.28530462280935	TERC;TERT
KEGG_2021_Human	Cell adhesion molecules	2/148	0.0136245920729854	0.04731713121293707	13.565068493150685	-18.413416454449223	CD34;HLA-A
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.0485495411122828	12.933006535947712	-17.54750234216727	CXCL8;IL6
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.0485495411122828	12.35625	-16.748364182562245	CXCL8;IL6
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.0485495411122828	12.35625	-16.748364182562245	IL6;THPO
KEGG_2021_Human	Hepatocellular carcinoma	2/168	0.01733904421063664	0.04993644732663353	11.900602409638553	-16.11078229535683	TERC;TERT
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.050203503010074715	11.614705882352942	-15.707848772731996	CXCL8;IL6
KEGG_2021_Human	NOD-like receptor signaling pathway	2/181	0.019962543247368986	0.05323344865965063	11.018156424581006	-14.859767863470836	CXCL8;IL6
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.05736059055601766	10.365789473684211	-13.920708621090329	CXCL8;IL6
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.05811989567750739	10.093589743589744	-13.525208778126117	CXCL8;IL6
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.058883029373982085	9.835	-13.147442958027579	HLA-A;IL6
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.06402054088131234	9.219483568075118	-12.240131856521	CXCL8;IL6
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.06926759377934028	8.519565217391305	-11.194266119915625	CXCL8;IL6
KEGG_2021_Human	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/26	0.03174141642153645	0.06926759377934028	35.74666666666667	-18.6524135039421	PIGA
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.07660042972741465	7.915991902834008	-10.280113155611538	CXCL8;IL6
KEGG_2021_Human	Allograft rejection	1/38	0.046083072411820386	0.09216614482364077	24.117117117117118	-13.560364723090352	HLA-A
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.09216614482364077	24.790123456790123	-13.876145105511855	IL6
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.09659379963028303	22.3	-12.692261742471414	CXCL8
KEGG_2021_Human	Type I diabetes mellitus	1/43	0.052002121863896134	0.09853033616317163	21.232804232804234	-12.171283962486152	HLA-A
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.10642709210495349	5.880699088145897	-7.115618067766183	HLA-A;TERT
KEGG_2021_Human	Cysteine and methionine metabolism	1/50	0.060233261208856796	0.10642709210495349	18.183673469387756	-10.63265628196324	DNMT3A
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.10642709210495349	18.962174940898347	-11.032973182262484	IL6
KEGG_2021_Human	Autoimmune thyroid disease	1/53	0.06374115884515756	0.1092705580202701	17.128205128205128	-10.081098986019231	HLA-A
KEGG_2021_Human	Viral myocarditis	1/60	0.07188046794101291	0.12035799283146348	15.08286252354049	-8.981081638876871	HLA-A
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.12329870011326621	14.347670250896057	-8.574814690072902	IL6
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.12424833733168125	13.895833333333334	-8.322075559905016	IL6
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.12775801981611182	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.12775801981611182	12.880837359098228	-7.74542097629872	CXCL8
KEGG_2021_Human	Antigen processing and presentation	1/78	0.09251851170984433	0.1387777675647665	11.531024531024531	-6.958150954500108	HLA-A
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.15582383733153563	9.961298377028713	-6.010407578745034	IL6
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.1663797479396277	8.592233009708737	-5.152341092635986	IL6
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.1663797479396277	8.2668743509865	-4.943743954376122	IL6
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.1663797479396277	8.592233009708737	-5.152341092635986	CXCL8
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.1663797479396277	3.816532258064516	-3.814605004177811	HLA-A;IL6
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1663797479396277	8.189300411522634	-4.893732148578802	IL6
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.1663797479396277	8.345911949685535	-4.994589105830365	IL6
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.16762892833756077	7.964964964964965	-4.748494648054986	IL6
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.18733654287656826	6.7846153846153845	-3.968927686510734	IL6
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.18733654287656826	6.7846153846153845	-3.968927686510734	HLA-A
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.19455096065025662	6.384863123993559	-3.698840756963446	IL6
KEGG_2021_Human	Phospholipase D signaling pathway	1/148	0.16890973234869874	0.20269167881843847	5.987150415721844	-3.427000500776257	CXCL8
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.20430853622241535	5.82560706401766	-3.3156870475343334	HLA-A
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.23442116431202284	4.896958410924891	-2.6658400097237527	IL6
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2444726720856773	4.5823152995927865	-2.441961042053517	CXCL8
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.2529181568710473	4.326732673267327	-2.2588473265567357	HLA-A
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.25879566453080405	4.137440758293839	-2.12256354972075	HLA-A
KEGG_2021_Human	Shigellosis	1/246	0.26614163456811335	0.29033632861976005	3.547845804988662	-1.6951894904190261	CXCL8
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.29202716760173736	3.4603806994245243	-1.6315316807371463	HLA-A
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.3081873723598427	3.184640522875817	-1.4307154955453085	IL6
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.3380701310556103	2.7900035958288387	-1.143955577607994	DNMT3A
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.37165874089814915	2.4283915643689014	-0.883914601009246	IL6
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3788995274675602	2.32487922705314	-0.8103995559567543	IL6
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	IL6
